ABSTRACT
INTRODUCTION
Macrosomia describes a newborn with an excessive birth weight of ≥ 4000 g or ≥ 4500 g at term and affects up to 10% of births, depending on the cut-off used for its definition. Large-for-dates pregnancies, defined as weight ≥ 90 th or ≥ 95 th centile for gestational age, reaching 40 weeks of gestation can result in macrosomia [1] [2] [3] [4] [5] . Macrosomia is associated with increased maternal and neonatal risks, including higher rates of emergency Cesarean section, operative vaginal delivery and injury of the birth canal, as well as higher risk of shoulder dystocia leading, in some cases, to permanent brachial plexus injury, fractures of the humerus or clavicle, birth asphyxia and stillbirth [2] [3] [4] [5] [6] [7] [8] [9] .
Traditionally, identification of fetuses suspected to be macrosomic has been based on biometric measurement by two-dimensional (2D) ultrasound (US), using the Hadlock formula described in 1985 10 . Only if fetal weight on 2D-US exceeds 4500 g (99 th centile at 40 weeks of gestation) in a diabetic or 5000 g in a non-diabetic woman is elective Cesarean delivery recommended, in order to reduce the potential harm associated with vaginal delivery 2, 11 . In a recent randomized controlled trial, fetuses suspected of being large for dates based on 2D-US weight estimation > 95 th centile were assigned randomly to induction of labor at 37-38 weeks' gestation or expectant management 12 ; the trial showed that induction of labor reduced the risk of shoulder dystocia as compared with expectant management. Accurate identification of large-for-dates fetuses is therefore important in order to improve obstetric management and avoid unnecessary interventions 13, 14 . It has been shown repeatedly that 2D-US, based on biparietal diameter, abdominal circumference and femur length, has a rather high relative error in estimating large-for-dates fetuses [15] [16] [17] [18] . Magnetic resonance imaging (MRI) based on measurement of fetal body volume (FBV) was introduced more than two decades ago and studies show that the relative error in estimating fetal weight using this method is 2-to 3-fold smaller than that of 2D-US [19] [20] [21] [22] [23] . A recent meta-analysis comparing 2D-US with MRI in predicting neonatal macrosomia concluded that although MRI is a very promising method, its accuracy regarding such a prediction remains uncertain 24 . Furthermore, a major drawback of using MRI routinely for the prediction of macrosomia is that planimetric measurement of FBV is time-consuming 25 . The purpose of this study was to evaluate the performance of a simple method of estimation of fetal weight (EFW) using MRI as compared with 2D-US in the prediction of large-for-dates neonates.
SUBJECTS AND METHODS

Study design
The study was approved by the local ethics committee, and all women gave written informed consent for use of their data in ongoing research. This was a single-institution cross-sectional study conducted at the Department of Radiology and the Fetal Medicine Unit of the University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium. Following the recent development by our group of purpose-designed software to assist planimetric measurement of FBV 26 , we retrieved retrospectively from our database data of women satisfying the entry criteria for the present study and applied the new method of MRI-EFW.
The study comprised two parts. The first concerned immediate prediction of large-for-dates neonates prior to delivery, and for this we retrieved data of women with singleton pregnancy scheduled for induction of labor or elective Cesarean section, who underwent both US and MRI examinations within 48 h before delivery and delivered a liveborn infant at ≥ 37 weeks of gestation. The second part of the study concerned prediction of large-for-dates neonates remote from delivery, and for this the inclusion criteria were women with singleton pregnancy evaluated between 35 + 0 and 37 + 6 weeks of gestation, who underwent both US and MRI examinations > 48 h before delivery and had a live birth.
In all women, gestational age was dated based on the first-trimester scan. Of the 353 women included in this study, 163 (46.2%) have been reported previously in a study that compared absolute MRI-EFW vs US-EFW with actual birth weight, but which did not examine the prenatal prediction of neonatal macrosomia using the semi-automated software for MRI-EFW 23 .
Ultrasound and MRI examinations
All prenatal US examinations were carried out using transabdominal sonography (RAB 4-8 L probe, Voluson 730 Expert, E8 or E10; GE Healthcare Ultrasound, Milwaukee, WI, USA) by maternal-fetal medicine specialists. Fetal weight was estimated using US (US-EFW) according to Hadlock et al. 10 , based on measurements of biparietal diameter, abdominal circumference and femur length.
MRI was performed using a clinical 1.5-T whole-body unit (Siemens Magnetom Avanto, Erlangen, Germany) with a gradient field strength of 45 mT/m. No maternal sedation was administered and the mother was not asked to hold her breath. Women were scanned in the supine position, with a combination of a six-channel phased-array body and six elements of the spine coil positioned over the lower pelvic area.
Following a scout scan in order to gather information about the orientation of the fetus, T2-weighted images were recorded using fast imaging with steady-state free procession (TrueFISP) sequences in the sagittal plane, with geometrical parameters of the T2-weighted images as follows: 10-46 adjacent slices on average adjusted according to fetal size with 4-mm slice thickness, intersection gap of 0 or 4 mm and 20 mm, field-of-view of 420 × 336 mm 2 , matrix 256 × 166, TR (repetition time)/TE (echo time) = 4.65 ms/2.33 ms, resulting voxel resolution of 1.6 × 2.1 × 4 mm 3 and bandwidth of 399 Hz/pixel. Sequences degraded by fetal motion were repeated with the same parameters. The time needed for acquisition of a sequence with 4-mm slice thickness and intersection gap of 20 mm was < 30 s.
FBV was delineated using a purpose-designed semi-automated computer-assisted method via a home-built user interface programmed with the MAT-LAB (matrix laboratory) environment (Matlab 2013a, The MathWorks, Inc, Natick, MA, USA) as previously described (Figure 1) 26 . Semi-automated FBV measurements were performed by a single maternal-fetal medicine specialist (C.K.) trained in planimetric measurements and blinded to prenatal US estimations and actual birth weight. In addition, all planimetric measurements were performed manually on a picture archiving and communication system (PACS) (Impax, Agfa-Gevaert, Mortsel, Belgium) as previously described 23 . Manual FBV measurements were performed by maternal-fetal medicine trainees supervised by C.K. or M.M.C. Total FBV could be measured in all fetuses, by both the semi-automated and PACS methods. The time required to perform the measurements using the semi-automated method was recorded.
MRI-EFW was calculated using the equation 0.12 + 1.031 × FBV (mL) = MRI weight (g), developed by Baker et al. 19 . In both parts of the study, weight centiles were calculated based on MRI-EFW, US-EFW and the gestational age at the time of the estimations, according to the curve centiles described by Yudkin et al. 27 . Birth centiles based on the actual birth weight of each neonate were calculated in the same way.
Statistical analysis
FBV measurements obtained using the semi-automated method were correlated with those obtained using PACS, using Pearson's correlation coefficient.
Receiver-operating characteristics (ROC) curves for the prediction of large-for-dates neonates (90 th and 95 th centile, separately) using MRI-EFW and US-EFW were constructed separately for the prediction of macrosomia within 48 h and > 48 h prior to delivery. ROC curves between MRI-EFW and US-EFW were compared using the method of DeLong et al. 28 . Detection rates of large-for-dates neonates by MRI-EFW and US-EFW were calculated for fixed falsepositive rates of 5%, 10% and 20%, and false-positive rates for fixed detection rates of 80%, 90% and 100%.
For women delivering within 6 h of MRI or US evaluation, EFW measurements obtained by each method separately (US, MRI using the semi-automated method and MRI using the manual method) were compared with the delivery weight considered as the gold standard, by calculating the following parameters as described by Bland and Altman 29, 30 : (1) bias, i.e. the mean of the proportionate difference (the difference between the EFW measurement and the delivery weight, divided by the delivery weight) and (2) proportionate 95% limits of agreement, i.e. 1.96 × SD of the mean of the proportionate difference. Graphical analysis was carried out by plotting the proportionate difference for each method as a function of the delivery weight considered as the gold standard.
Data are presented as median (range) unless mentioned otherwise. Statistical analysis was performed using Excel version 15.0 (Microsoft Corp., Redmond, WA, USA) and MedCalc version 15.11.4 (Mariakerke, Belgium). P < 0.05 was considered statistically significant.
RESULTS
During the study period, between March 2011 and May 2016, 270 women satisfied the inclusion criteria and were included in the first part of the study, and 83 women were included in the second part of the study. Demographic data of women included in each part of the study are summarized in Table 1. FBV measurements obtained using the semi-automated method and those based on PACS correlated significantly following the linear equation: FBV-semiautomated = −94.90 + 1.04 × FBV-PACS (r 2 = 0.96; P < 0.001) (Figure 2 ). Median time needed for acquisition of FBV planimetric measurements using the semi-automated method was 3.5 (range, 1.5-5.5) min.
Prediction within 48 h before delivery
MRI and US measurements were performed at a median gestational age of 39.1 (range, 36.9-42.1) weeks and 39.1 Data are given as mean ± SD or n (%). BMI, body mass index. Area under the ROC curve (AUC) for the prediction of birth weight ≥ 90 th centile by prenatal MRI was 0.985 (standard error (SE), 0.006; P < 0.001) and by US was 0.900 (SE, 0.022; P < 0.001). Pairwise comparison of the ROC curves showed a significant difference between the AUCs (difference, 0.085; SE, 0.020; P < 0.001) (Figure 3a) .
AUC for the prediction of birth weight ≥ 95 th centile by prenatal MRI was 0.985 (SE, 0.006; P < 0.001) and by US was 0.950 (SE, 0.014; P < 0.001). Pairwise comparison of the ROC curves showed a significant difference between the AUCs (difference, 0.036; SE, 0.014; P = 0.01) (Figure 3b) . th centile by prenatal MRI was 0.957 (SE, 0.024; P < 0.001) and by US it was 0.880 (SE, 0.044; P < 0.001). Pairwise comparison of the ROC curves showed a significant difference between the AUCs (difference, 0.077; SE, 0.039; P = 0.045) (Figure 3c ).
Detection rates of birth weight ≥ 90 th and ≥ 95 th centile by MRI-EFW and US-EFW performed > 48 h prior to delivery for fixed false-positive rates of 5%, 10% and 20% and for fixed detection rates of 80%, 90% and 100%, are summarized in Table 2 .
Accuracy of MRI vs US for estimation of EFW
Of the 270 women assessed within 48 h before delivery, 53 (19.6%) had a prenatal US examination and 48 (17.8%) had a prenatal MRI examination within 6 h before delivery. Bland-Altman scatterplots showed better agreement of MRI-EFW with the delivery weight, whether using the semi-automated method or the PACS method, as compared with US-EFW ( Figure 4 and Table 3 ). For US-EFW, 95% of fetal-weight estimates were within a range of ± 588 g, whereas for MRI-EFW the range was ± 227 g using the semi-automated method and ± 149 g using the PACS method.
DISCUSSION
Our findings have demonstrated that MRI-EFW performed immediately (≤ 48 h) prior to delivery in women delivering at term can predict large-for-dates neonates, i.e. those with weight ≥ 90 th and ≥ 95 th centile for gestational age, significantly better than US-EFW. The same trend was observed for prediction performed remote from delivery (> 48 h) at 35-37 weeks of gestation. Furthermore, our study has shown that MRI planimetry using our purpose-designed semi-automated method correlates strongly with the manual method using PACS, yet allows fetal segmentation in only 3 min on average. Methods to diagnose macrosomia prenatally are based on clinical assessment and/or fetal weight estimated by 2D-or 3D-US during the third trimester but are quite often inaccurate. A study designed to evaluate the limits of accuracy with 2D-US in 628 women concluded that it was not possible to achieve further improvement in fetal weight estimation with conventional 2D-US biometry 31 . Caregivers should be aware that estimates of fetal weight using conventional 2D-US biometry will lie within the range of about ± 600 g, which can be more than halved using MRI with the semi-automated method.
Recently, combined screening for macrosomia using maternal factors and 2D-US fetal biometry performed at 35-37 weeks of gestation in a study of 6181 singleton pregnancies showed that about 75% of fetuses with weight > 95 th centile could be predicted at a 10% false-positive rate 32 . The use of MRI has been evaluated mainly in the overall prediction of fetal weight, but not specifically in large-for-dates fetuses. One meta-analysis compared prediction of macrosomia between MRI and US estimates, but included MRI studies that were not primarily aimed at assessing macrosomia and, most importantly, MRI and US estimates did not all relate to the same women 24 . To our knowledge, this is the first study to compare, in a large number of cases and in the same women, MRI-EFW vs US-EFW in the prediction of large-for-dates neonates. Based on our data, for a false-positive rate of about 30% for US-EFW at 35-37 weeks and of about 20% immediately before delivery, all newborns ≥ 95 th centile could be detected. These figures drop to a false-positive rate of about 15% and 7%, respectively, when assessment is performed by MRI. A two-stage strategy by which MRI is included in decision-making could include a first screening by 2D-US at 35-37 weeks. About 30% of this subgroup would be scheduled to undergo MRI at the 39 th week of gestation, if delivery has not occurred by then. Such a strategy would allow the detection of all large-for-dates neonates ≥ 95 th centile at the cost of having about a quarter of the population undergo MRI, with a false-positive rate of < 3%. Although it could be argued that, in order to avoid a 'spectrum' bias, our study should have been conducted on a population at high risk for large for dates, rather than on a rather unselected population, only by conducting a study on an unselected population could the design of a two-stage strategy be defined for the future.
Our approach to management of fetuses with suspected macrosomia is based mainly on the cost analysis by Rouse et al. 11 followed by the ACOG and RCOG/NICE guidelines and is likely to change dramatically in the future with the availability of a simple and more accurate method for prediction of macrosomia. Women with a macrosomic fetus who receive appropriate counseling about the maternal and neonatal risks of vaginal birth vs elective Cesarean delivery are more likely to choose the latter, especially when the proportion of falsely classified macrosomic fetuses is low. Although appropriate studies are required to confirm this, it is likely that implementation of MRI in a two-stage strategy could make cost-effective changing the cut-offs for Cesarean delivery to the 95 th centile or even lower for diabetic mothers and/or mothers of small stature 33 . In our cohort, 17.8% of newborns had birth weight ≥ 90 th centile and 11.1% ≥ 95 th centile, which is a much higher prevalence than that in a routine population. For instance, in 5920 consecutive pregnancies with available data from our maternity unit, 458 (7.7%) newborns had weight ≥ 90 th , 228 (3.9%) ≥ 95 th and 55 (0.9%) ≥ 99 th centile for gestational age. The obvious explanation for this discrepancy is that our sample was biased towards women who were more likely to have a macrosomic newborn because recruitment was based on the indication for planned delivery; however, this limitation is inherent to the study design and could not be avoided.
In our study we used a 1.5-T cylindrical magnet with 60-cm bore. In a previous study we showed that about 1% of eligible women who give consent for MRI-EFW cannot be accommodated in the MRI machine or feel discomfort because of obesity, leading to interruption of the examination 23 . This rate could be even higher in other countries, thus leading to failure of the technique in a higher proportion of pregnant women 34 , and this should be taken into account before further implementation of this technique. The wider availability of 70-cm bore magnets overcomes this problem since it can accommodate even morbidly obese women 35 . Further, fetal safety is not an issue for 1.5-T magnets 36 or for 3-T magnets given the sequence regimens used for such an indication 37 . Finally, it is unlikely that real claustrophobia could play a major role in failure to acquire a FBV at MRI given that acquisition of the sequence is feasible in less than 1 min.
Simplification of the MRI-EFW technique using our semi-automated method has solved one of the major limitations that has hampered its clinical implementation for the past two decades. We have shown, in a large number of women, that the semi-automated method of planimetry correlates highly with the manual method, yet a dramatically shortened time of about 3 min is required for segmentation, as compared with previous reports in which up to 1 h was needed 23 . We acknowledge some limitations of our study. First, the single-center nature of the study does not allow straightforward extrapolation of the results to other obstetric units; the main issue is obviously to test the developed software on images acquired using a different type of MRI magnet. Second, the number of cases included for prediction of neonatal macrosomia remote from delivery, which represents the group of interest, was relatively small and evaluation was performed within a wide range of gestational ages. Third, we did not study the socioeconomic impact of introducing MRI-based fetal weight estimation on the current medical practice and whether it could change the rate of unnecessary Cesarean sections. It is worth noting that there is a very wide range of Cesarean section rates among countries and the same applies to availability of MRI equipment. Although such an evaluation is complex and beyond the scope of the present study, a future study evaluating the feasibility of introducing MRI-EFW in clinical practice is essential.
In conclusion, MRI-EFW applied to a population with a high prevalence of macrosomic fetuses performed significantly better than US-EFW in the prediction of large-for-dates neonates, when assessment was performed both immediately prior to and remote from delivery. More importantly, and unlike previous studies evaluating MRI-EFW, the described method is quite simple, reproducible 38 and therefore very promising for future clinical implementation. MRI-EFW also seems promising in twin pregnancy 39 . Further research is needed to establish the best strategy and cost benefit of clinical implementation of this method and whether it could have a real impact on obstetric outcome of mothers and newborns. Furthermore, aspects such as the best fit formula deriving MRI-EFW from FBV should be evaluated, taking into account gestational age at evaluation and fetuses of diabetic mothers. A study is under way to determine the extent to which the use of this simplified method of MRI-EFW on a large number of unselected women at the 36 th week of gestation can improve the prediction of large-for-dates neonates as compared with US-EFW (ClinicalTrials.gov Identifier no. NCT02713568).
